FilingSEC EDGAR8-K
Rallybio Approves Merger with Avenzo and Declares Special Cash Distribution
· SEC accepted
StageShareholder Approval
Filing content
Stockholders approved the merger with Avenzo Therapeutics and related proposals. The company also declared a special cash distribution of $13.90 per share in connection with the merger.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…